These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 19408052)

  • 21. Extreme analysis of risk factors for lymph node metastasis in gastric cancer.
    Ma Y; Zhu G; Xue Y; Zhang Y; Zhang M
    Hepatogastroenterology; 2010; 57(98):362-6. PubMed ID: 20583444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant prognostic factors in patients with node-negative gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
    Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer.
    Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E
    J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
    Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
    Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion.
    Higashi H; Natsugoe S; Ishigami S; Uenosono Y; Matsumoto M; Nakajo A; Miyazono F; Hokita S; Takao S; Aikou T
    World J Surg; 2003 Apr; 27(4):455-9. PubMed ID: 12658492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node micrometastasis in node negative early gastric cancer.
    Kim JJ; Song KY; Hur H; Hur JI; Park SM; Park CH
    Eur J Surg Oncol; 2009 Apr; 35(4):409-14. PubMed ID: 18573635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection.
    Deng JY; Liang H; Sun D; Zhan HJ; Wang XN
    J Surg Oncol; 2008 Oct; 98(5):343-8. PubMed ID: 18668672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
    Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
    Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.